Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2011 Feb 25;20(5):818–825. doi: 10.1158/1055-9965.EPI-10-1213

Table 5.

Multivariate adjusted rate ratios for colorectal adenomas according to aspirin use and two major dietary patterns

Quintile Cases Person-years Adjusted IRR (95% CI)1
Nonaspirin user
Western 1 88 24,841 1.00
2 100 25,034 1.16(0.87-1.55)
3 101 25,091 1.22(0.90-1.63)
4 91 24,849 1.14(0.84-1.54)
5 103 24,805 1.32(0.97-1.78)
P, trend 0.13
Prudent 1 104 25,944 1.00
2 96 25,370 0.89(0.67-1.19)
3 95 25,014 0.83(0.62-1.11)
4 99 24,343 0.83(0.62-1.11)
5 89 23,949 0.71(0.51-0.96)
P, trend 0.03

Aspirin user
Western 1 24 5,893 1.00
2 20 5,647 0.97(0.52-1.77)
3 28 5,627 1.29(0.83-1.56)
4 27 5,812 1.17(0.82-2.58)
5 34 5,803 2.07(1.18-3.63)
P, trend < 0.01

Prudent 1 20 4,790 1.00
2 30 5,363 1.23(0.69-2.18)
3 27 5,616 0.95(0.52-1.73)
4 31 6,244 0.84(0.46-1.52)
5 25 6,768 0.61(0.32-1.15)
P, trend 0.04
1

Adjusted for age, BMI, education, family history of colorectal cancer, vigorous physical activity, total energy intake, menopausal status, alcohol consumption, smoking status and female hormone use.